.-We examined whether the glia limitans (GL) influences pial arteriolar relaxation elicited in vivo by the purinergic (P2Y1 receptor) agonist ADP in female rats, and whether that influence is altered in ovariectomized (Ovx) females. A validated model for GL injury was used, topical application of the gliotoxin L-␣-aminoadipic acid (L-␣AAA), 24 h before the study. In both intact and Ovx females, L-␣AAA had no effect on responses to the NO donor, S-nitroso-Nacetyl penicillamine, but ADP-induced pial arteriolar dilations were significantly reduced (by 33-90%), compared with vehicle-treated controls. When N G -nitro-L-arginine (L-NNA) was administered to L-␣AAA-treated rats, the ADP response was virtually lost in intact females, but no further reductions were observed in the Ovx rats. On the other hand, in L-␣AAA-treated Ovx females, when the gap junction blocker, Gap 27, was subsequently added to the suffusate, ADP reactivity fell to very low levels. In vehicle-treated control rats, L-NNA and Gap 27 reduced ADP reactivity by ϳ50% in intact and Ovx females, respectively. An earlier study indicated that the endothelium was a key site of influence for L-NNA (intact) and Gap 27 (Ovx). Thus present and previous results imply that the ADP response in pial arterioles represents the additive actions of an endothelial and a GL component. That supposition was confirmed in the present study by the finding that combining endothelial and GL injury produced an essentially complete loss of ADP reactivity in both intact and Ovx females. Finally, topical application of the selective P 2Y1 antagonist, MRS-2179, was associated with a nearly complete suppression of the ADP response in both intact and Ovx females. These results suggest that 1) ADP-induced pial arteriolar dilation involves additive contributions from P2Y1 receptors present in both vascular endothelium and the GL; 2) the influence of the GL component is not altered by ovariectomy; and 3) the gap junction-dependent component of the ADP response in Ovx females is unlikely to include the GL and probably resides in the vessels themselves. endothelium-derived hyperpolarizing factor; gap junction; nitric oxide; purinergic receptor WE RECENTLY REPORTED (20, 21 ) that in vivo pial arteriolar dilations elicited by the purinergic P 2 Y 1 agonist ADP are partially dependent on endothelial nitric oxide (NO) synthase (eNOS) in gonadally intact rats. However, in ovariectomized (Ovx) females, the NO dependency was lost, but the magnitude of the response remained unchanged. This was due to an increase in the contribution from an NO-independent (NOS inhibitor insensitive), but still endothelium-dependent, element, one that had the hallmarks of an endothelium-dependent hyperpolarizing factor (EDHF). Additional findings indicated that the apparent EDHF component involved gap junctions (20) . Irrespective of the endothelium-related mechanism, ϳ50% of the ADP response in both intact and Ovx rats was insensitive to endothelial injury and, in endothelium-intact vessels, NOS inhibition or gap junctional blockade (20). Indeed, in that study, a major gap junctional protein, connexin 43 (Cx43), was found to be well expressed not only in pial arterioles, but also in the underlying layer of glial processes, termed the glia limitans (GL). In another recent study, we obtained evidence suggesting that the GL and gap junctions play significant roles in hypercapnia-induced relaxation of pial arterioles (19).
endothelium-derived hyperpolarizing factor; gap junction; nitric oxide; purinergic receptor WE RECENTLY REPORTED (20, 21) that in vivo pial arteriolar dilations elicited by the purinergic P 2 Y 1 agonist ADP are partially dependent on endothelial nitric oxide (NO) synthase (eNOS) in gonadally intact rats. However, in ovariectomized (Ovx) females, the NO dependency was lost, but the magnitude of the response remained unchanged. This was due to an increase in the contribution from an NO-independent (NOS inhibitor insensitive), but still endothelium-dependent, element, one that had the hallmarks of an endothelium-dependent hyperpolarizing factor (EDHF). Additional findings indicated that the apparent EDHF component involved gap junctions (20) . Irrespective of the endothelium-related mechanism, ϳ50% of the ADP response in both intact and Ovx rats was insensitive to endothelial injury and, in endothelium-intact vessels, NOS inhibition or gap junctional blockade (20) . Indeed, in that study, a major gap junctional protein, connexin 43 (Cx43), was found to be well expressed not only in pial arterioles, but also in the underlying layer of glial processes, termed the glia limitans (GL). In another recent study, we obtained evidence suggesting that the GL and gap junctions play significant roles in hypercapnia-induced relaxation of pial arterioles (19) .
The central hypothesis of this investigation is that the GL plays a key role in ADP-induced pial arteriolar dilation. To address that hypothesis, we examined whether the GL is important to the endothelium-independent portion of ADPinduced pial arteriolar relaxation; whether GL contributions are altered by chronic depletion of reproductive hormones; whether the gap junctional contributions to the ADP response in Ovx females involve the GL; and whether the ADP response is mediated by P 2 Y 1 receptors present in both vascular tissue (principally endothelium) and the GL. To that end, we compared the effects of topical applications of the gliotoxin L-␣-aminoadipic acid (L-␣AAA) on the ADP response in intact vs. Ovx females. The GL-injured rats were studied in the absence and presence of N G -nitro-L-argninine (L-NNA) and the gap junctional blocker Gap 27 (see Ref. 6) . Because recent findings from our laboratory indicated that L-NNA and Gap 27 influenced the endothelial component of the ADP response in intact and Ovx females, respectively (20) , we hypothesized that combining L-␣AAA with L-NNA or Gap 27 would result in the disappearance of ADP reactivity. As a further test of that hypothesis, pial arteriolar ADP reactivity was examined in rats subjected to combined endothelial and GL injury. Finally, ADP responses were monitored in the absence and presence of the selective P 2 Y 1 antagonist MRS-2179. The findings of these experiments suggested that pial arteriolar ADP-induced dilations in female rats occur as the result of additive contributions from P 2 Y 1 receptors present in endothelium and GL, irrespective of hormone status.
METHODS
The study protocol was approved by the Institutional Animal Care and Use Committee. Two groups of female Sprague-Dawley rats (200 -250 g at arrival) were used: intact and ovariectomized (Ovx).
Ovariectomies were performed by the vendor (Charles River) 1 wk before shipment. Studies were performed at ϳ4 wk after the date of arrival. Pial arteriolar reactivities were evaluated through closed cranial windows placed on the day preceding study (19) . For window placement, the rats were anesthetized with halothane, intubated, paralyzed with a short-acting muscle relaxant (vecuronium), and mechanically ventilated with a 0.8% halothane-70% N 2O-30% O2 gas mixture. After window preparation, 300 l of an artificial cerebrospinal fluid (aCSF) solution with or without L-␣AAA (2 mM) were injected into the space under the cranial window (19) . The cranial window access ports were then plugged, and the skin overlying the skull was sutured together. The animal was permitted to recover from anesthesia, extubated, and returned to its cage. On the day of study, after anesthesia induction with halothane and paralysis (curare), the rats were tracheotomized and mechanically ventilated. Bilateral femoral arterial and venous catheters were inserted under anesthesia with 0.8% halothane-70% N 2O-30% O2. After catheterization, the rat was placed in a head holder, and the cranial window inflow, outflow and intracranial pressure monitoring cannulae were connected. Halothane was discontinued, and a 10 g/kg fentanyl bolus was given intravenously. During the study, the rats were maintained with fentanyl (25 g ⅐ kg Ϫ1 ⅐ h Ϫ1 iv) and 70% N2O-30% O2. The space under the window was filled with aCSF (pH Ϸ7.35-7.40) that was equilibrated with a gas mixture consisting of 20% O 2-5% CO2-balance of N2. The 37°C aCSF solution was suffused at 0.5 ml/min. Body temperature was controlled at 37°C, and mean arterial pressure and intracranial pressure were monitored continuously during the experiment. Measurements of the diameters of pial arterioles (25-50 m) were made using video microscopy (see Ref. 18) . In all experiments, the initial diameter measurements were made 1 h posthalothane and after 40-min drug-free aCSF suffusion.
The rats were divided into four principal experimental subgroups: intact vehicle; intact L-␣AAA; Ovx vehicle; and Ovx L-␣AAA. For the intact females, after measurement of baseline diameter values, ADP, at concentrations of 10 and 100 M, was suffused into the space under the cranial window (5 min each concentration). After 10 min of drug-free aCSF suffusion, a baseline measurement was made, and the NO donor S-nitroso-N-acetyl penicillamine (SNAP) was sequentially suffused at 0.1 and 1.0 M (5 min at each dose). After a return to baseline, L-NNA (1 mM) was added to the aCSF and suffused for 60 min, and the responses to ADP and SNAP were again evaluated. Time control rats, from vehicle and L-␣AAA-treated groups, where L-NNA was omitted from the aCSF, were also studied. No changes in ADP or SNAP reactivity were noted in these animals (data not shown). In the Ovx rats, a similar protocol was used, but with one additional step. Thus the responses to ADP (10 and 100 M) and SNAP (0.1 and 1.0 M) were evaluated as in the intact females: first in the absence and then in the presence of L-NNA. Subsequently, a suffusion of the Cx43 and Cx37 gap junction inhibitory peptide, Gap 27 (300 M), was initiated and maintained for 1 h before reevaluation of ADP responses. No changes in ADP or SNAP reactivities were seen in time controls, where L-NNA and L-NNA ϩ Gap 27 were omitted from the aCSF solution (not shown).
Two additional experimental protocols were performed. In the first, we sought to obtain further evidence in support of the hypothesis that the pial arteriolar vasodilating response to ADP, in intact and Ovx females, is a reflection of the additive contributions from vascular endothelium and the GL. To that end, L-␣AAA-treated rats were subjected to a light plus dye (L/D) endothelial injury strategy, utilized in several previous studies in our laboratory (e.g., Ref. 20) . For these experiments, at 24 h after L-␣AAA treatment, ADP (10 and 100 M) and SNAP (0.1 and 1.0 M) reactivities were measured. Subsequently, the animals were subjected to L/D injury, where mercury light was passed through a filter that allowed transmission only at 450 -490 nm. The light passed coaxially through the microscope objective and was focused on an area including the vessels being studied. Two percent fluorescein dye (0.8 ml/100 g body wt) was given intravenously, and the mercury light was turned off 55 s after the fluorescein dye infusion was initiated. The responses to ADP or SNAP were then reevaluated. For the second protocol, the P 2Y1 receptor dependency of ADP-induced pial arteriolar dilations was examined in vehicle-injected intact and Ovx females. In these rats, dose-related responses to suffusions of ADP (10, 30, and 100 M) and then adenosine (10 and 100 M) were measured. After reestablishment of baseline diameters, via suffusion of drug-free aCSF, a suffusion of MRS-2179 (10 M) was initiated. After 60 min, ADP and adenosine reactivities were again evaluated. The EC 50 for MRS-2179 in vitro has been reported to be in the range of 0.1-0.3 M, but is ineffective toward other P 2Y receptors at concentrations up to 30 M (1, 8) .
Arterial blood samples were taken at 30-min intervals for Pa O 2 , PaCO 2 , and pH analysis using a blood gas/pH analyzer (model ABL 520, Radiometer; Copenhagen, Denmark). PaO 2 (Ն100 mmHg), PaCO 2 (30 -40 mmHg), and pH (7.40) were maintained during the study.
All reagents were obtained from Sigma (St. Louis, MO) and dissolved in aCSF unless otherwise stated. Gap 27 peptide (SRPTEKTIFII) was synthesized by the Protein Research Laboratory at the University of Illinois at Chicago. The purity of the peptide was Ͼ95%. Values are presented as means Ϯ SE. Comparisons of arteriolar diameter values within groups were made using one-way repeated-measures ANOVA, combined with a post hoc Tukey analysis. Analyses of diameter changes between groups were made using Student's t-test. A P value Ͻ 0.05 was considered as significant.
RESULTS
In all experiments, the physiological variables were within normal limits. Thus Pa CO 2 , pH, and mean arterial blood pressure in these groups did not show any significant differences when comparing initial and final values over the course of the experiments (Table 1) . Not included in Table 1 are the arterial PO 2 values, which were maintained at Ͼ100 mmHg in all rats studied. Also provided in Table 1 are the initial pial arteriolar diameters.
No changes were seen in the pial arteriolar responses to the NO donor, SNAP, in vehicle-or L-␣AAA-treated intact and Ovx female rats (Fig. 1) . The absence of any change in vascular reactivity to SNAP suggests that neither ovariectomy nor L-␣AAA alters vascular smooth muscle function. The absence of any effect of L-NNA (1 mM, topical application) confirms that SNAP acts independently of endogenous generation of NO.
Pial arteriolar responses to suffusions of ADP (10 and 100 M) in vehicle-treated and L-␣AAA-treated intact females, in the absence and presence of L-NNA, are shown in Fig. 2 . As previously shown by us, in the intact females, NOS inhibition reduced the ADP response by ϳ50%. In rats exposed to topically applied L-␣AAA for 24 h, ADP reactivity was reduced, relative to vehicle controls, by 33% (100 M ADP) to 70% (10 M ADP) in the absence of NOS inhibition. Moreover, on addition of L-NNA, ADP reactivity was reduced substantially further, by 82-100% from the initial response observed in the vehicle group. These seemingly additive effects of L-NNA and L-␣AAA suggest that NO and the GL support separate components of the ADP response in intact females.
Pial arteriolar responses to ADP in vehicle-treated and L-␣AAA-treated Ovx females, in the absence and presence of L-NNA and L-NNA ϩ Gap 27, are summarized in Fig. 3 . As previously shown by us (20, 21) , although pial arteriolar reactivity to ADP is not significantly different in Ovx vs. intact females (see Fig. 2 ), NOS inhibition has no effect on the ADP response in Ovx rats (consistent with the loss of eNOS dependency). In Ovx females treated with L-␣AAA, the pial arteriolar response to ADP was reduced by 35-90% from the response seen in vehicle-treated Ovx females, with no further changes on addition of L-NNA. However, when the gap junctional inhibitor Gap27 (which preferentially affects Cx43-and Cx37-containing gap junctions) was applied, ADP reactivity at the lower concentration completely disappeared and was mark- edly repressed (by Ͼ80% from the initial response in the vehicle group) at the higher ADP concentration. It should be noted that Gap 27 has no effect on pial arteriolar reactivity to ADP in intact females (20) . The effects of GL injury and gap junctional blockade seem to be generally additive, although the combination of GL injury and gap junction blockade appears to exceed what one might expect if the effects of L-␣AAA and Gap 27 were completely independent of one another. Nevertheless, the mostly additive nature of these results suggests that the gap junctional dependency and astrocytic (GL) influence, to a large degree, involve separate components of the pial arteriolar response to ADP in the Ovx female. The fact that the gap junctional component does not seem to be substantially affected by injury to the GL suggests that the gap junctions involved in the ADP response in Ovx females are mostly nonastrocytic. A likely location for these gap junctions would be within the vessels themselves.
As a further demonstration that, irrespective of hormone status, ADP-induced pial arteriolar dilation involves the additive effects of an endothelium-dependent and an astrocytedependent component, additional rats were studied where the ADP response was evaluated first at 24 h after L-␣AAA-induced GL injury and, subsequently, after acute L/D-induced endothelial injury. These data are provided in Fig. 4 . Similar to the results presented earlier, L-␣AAA treatment was accompanied by ADP responses that were 40 -70% lower than the control responses (control values given in Figs. 2 and 3) . On L/D treatment, the response at the lower ADP concentration (10 M) completely disappeared, and the response at 100 M ADP was reduced to ϳ10% of the control value. The absence of any changes in the pial arteriolar responses to SNAP (Fig. 5) confirms that the L/D procedure did not injure vascular smooth muscle.
The P 2 Y 1 receptor dependency of ADP-induced pial arteriolar relaxation is illustrated by results summarized in Fig. 6 . Thus ADP responses were almost completely eliminated in the presence of MRS-2179 in both intact and Ovx females. The selectivity of the MRS-2179 effect was supported by the absence of any significant changes in the magnitude of the pial arteriolar relaxations elicited by the P 1 agonist adenosine (Fig. 7) .
DISCUSSION
There were several key findings in these studies. First, the GL has a profound influence on ADP-induced pial arteriolar dilation in female rats. Second, that influence is not altered by changes in hormone status. Third, the GL contribution in females involves the NO-insensitive and endothelium-independent component of the ADP response. Accordingly, in the intact female, the NO-dependent and the astrocyte-derived elements, in an additive manner, seem to account for nearly all of the pial arteriolar response to ADP. Furthermore, because the endothelium-dependent and the L-NNA-inhibitable components completely overlap (20) and because evidence indicates that pial arteriolar ADP-induced dilations in rats are not influenced by neuronal NOS (nNOS) (17) , the "non-GL" component, in all likelihood, is eNOS. In the Ovx female, the NO-dependent component is replaced by a mechanism related to gap junctions (20, 21) . Thus, in contrast to hormonally normal females, virtually all of the ADP response in the Ovx female can be attributed to the mostly additive actions of a gap junctional element and an astrocyte-associated element. Simi- lar to the non-GL component indicated in intact females, the gap junctional element appears to involve the endothelium. This is based upon the parallel observations in the current study that either gap junctional blockade or endothelial injury, when added on top of L-␣AAA-induced GL injury, elicits a nearly complete loss of ADP reactivity.
In a recently published report (19) , we established that L-␣AAA selectively damages the GL while (functionally) sparing vascular cells and neurons. In that study, we also obtained evidence that the GL plays an important role in supporting hypercapnia-induced pial arteriolar dilation. Additional findings indicated that Cx43, and presumably gap junctions, participated in that response. However, in that instance, results suggested that gap junctions residing in astrocytes were involved.
Although both involve multicellular influences, there are major differences in stimulus/vascular response coupling when comparing in vivo pial arteriolar responses to hypercapnia vs. ADP. One obvious difference is that ADP acts via a purinergic receptor (mostly P 2 Y 1 ; see Ref. 16 ), whereas hypercapnia does not. As such, one might look to the sites of P 2 Y 1 expression to derive clues as to the mechanisms at play in an ADP response that includes a vascular, as well as an extravascular, component. Of particular relevance to the present investigation, P 2 Y 1 receptors have been shown to be well expressed in rodent astrocytes (e.g., Ref. 22) . Endothelial cells are reported to be another site of P 2 Y 1 expression, which is consistent with the purported role of this receptor subtype in cerebral endotheliumderived NO generation (7). In the brain, evidence points to the endothelial presence of P 2 Y 1 message in arteries (11) , although immunohistochemical analysis has not confirmed endothelial expression of P 2 Y 1 protein (14) . Nevertheless, in the present study, P 2 Y 1 blockade with the selective antagonist MRS-2179 was associated with a virtually complete loss of ADP reactivity in pial arterioles. Because, in female rats, endothelium (see Fig.  4 and Ref. 20) and astrocytes appear to contribute roughly equally (i.e., 50/50) to the pial arteriolar ADP response, the results obtained with P 2 Y 1 antagonist applications would seem Fig. 8 . Postulated mechanisms of ADP-induced dilation of pial arterioles in intact and Ovx females. In both groups, the vasodilating response is the result of the additive contributions from P2Y1-dependent endothelial and astrocytic (glia limitans; GL) components. The major difference between intact and Ovx females resides in the endothelial component. Thus, in the intact female, ADP engagement of the receptor stimulates production of endothelial NOS (eNOS)-derived NO. On the other hand, in the Ovx female, even though eNOS function is impaired, there is no loss in ADP reactivity, because P2Y1 activation in endothelium now elicits a response that is endothelium-derived hyperpolarizing factor-like (21) and gap junction dependent (20) . In both groups, ADP-induced activation of P2Y1 receptors in the underlying astrocytes accounts for ϳ50% of the pial arteriolar response to ADP. We suspect that this initiates a process capable of eliciting vascular smooth muscle relaxation. The fact that the gap junctional component does not seem to be appreciably affected by injury to the GL suggests that the gap junctions involved in Ovx females are nonastrocytic. Moreover, on the basis of results from experiments employing endothelial injury (Fig. 4 and Ref. 20) , the gap junctions are likely to reside in the vascular compartment and may include interendothelial and/or myoendothelial communication.
to support the presence of endothelial P 2 Y 1 receptors, at least in pial vessels. This apparent incongruity between results obtained using pharmacological and immunohistochemical approaches may simply be a function of an insufficient sensitivity to P 2 Y 1 antibodies, although we cannot completely discount the possibility, however unlikely (1) , that MRS-2179 may be interacting with another P 2 Y variant or that P 2 Y 1 expression may be relatively greater in pial arterioles compared with the rest of the cerebral vasculature. The similar efficacies of MRS-2179 and combined endothelial and GL injury in effecting a nearly total blockade of pial arteriolar ADP reactivity also imply that the P 2 Y 1 receptors involved reside almost exclusively in endothelium and the GL. This leaves little, if any, room for contributions from the P 2 Y 1 receptors that appear to be present in neurons (12) and cerebral vascular smooth muscle (11) . Furthermore, the finding that L-␣AAA-and L/D-induced injuries do not damage cortical neurons and pial arteriolar smooth muscle (Fig. 5 and Ref. 19 ), yet ADP reactivity is lost nonetheless, makes it even less likely that P 2 Y 1 receptors in those cells contribute in any meaningful way.
The fact that application of the P 2 Y 1 antagonist was associated with a loss of ADP reactivity in both intact and Ovx females suggests that activation of endothelial P 2 Y 1 receptors not only can stimulate eNOS-derived NO generation but also, under the "right" circumstances, is capable of promoting a gap junction-related vasodilation that has characteristics of an EDHF (20) (4) . While this implies a Ca 2ϩ -dependent astrocyte-derived factor, the nature of this apparent factor is unknown. Certainly, paracrine factors generated by Ca 2ϩ -activated enzymes must be given serious consideration. Candidate enzymes include nNOS and the Ca 2ϩ -dependent PLA 2 isoforms. NO generated via nNOS action seems unlikely, in light of recent findings from our laboratory showing that topical application of the neuronal NOS-selective inhibitor ARR-17477 (at least in male rats) had no effect on pial arteriolar responses to ADP suffusions (17) . With regard to PLA 2 , one might consider the downstream metabolism of a principal product of PLA 2 action, i.e., arachidonic acid (AA). Indeed, evidence exists linking P 2 Y 1 receptor activation to AA release in astrocytes (3). There are well-established vasodilating substances generated via AA metabolic pathways. These include cyclooxygenase-1 (COX-1) products, like prostacylin, or products of the cytochrome P-450-2C11 epoxygenase. However, in earlier studies, we failed to observe any effects of COX-1 or epoxygenase inhibitors on the ADP response of pial arterioles (21) . Nevertheless, whereas the absence of any effect of epoxygenase inhibition would be consistent with a lack of any influence from de novo epoxide generation, it does not negate the participation of epoxides released from preformed pools. There are additional PLA 2 -related candidates one might consider. The possibility exists that AA itself, in the absence of further metabolism, may promote vasodilation, for example, via interaction with AA-sensitive membrane ion channels (2) . AA has also been shown to be a potent vasodilator when applied directly to cerebral arteries and arterioles in vivo (e.g., Refs. 5 and 15). However, that AA action appears to be attributable to its metabolism via the cyclooxygenase or lipoxygenase pathway. Although a COX-1-generated AA metabolite has been essentially eliminated as a potential mediator of ADP-induced pial arteriolar relaxation in our animals, it may be of some value, in future studies, to examine whether a lipoxygenase pathway product or AA itself is involved.
In conclusion, the GL appears to have a significant influence on ADP-induced pial arteriolar dilation in female rats, irrespective of hormone status. That contribution involves the NOinsensitive component of the ADP response. In fact, in the intact female, the eNOS-dependent and the astrocyte-derived elements, in an additive manner, seem to account for nearly all of the pial arteriolar response to ADP (Fig. 8A) . In the Ovx female, the NO-dependent component is replaced by a mechanism related to gap junctions and EDHF. Thus a substantial portion of the ADP response in the Ovx female can be accounted for (additively) by a gap-junctional (EDHF) element and an astrocytic element (Fig. 8B) . In contrast to the pial arteriolar response to hypercapnia (19) , the gap junctions involved would appear to be nonastrocytic (probably vascular). In either case, it appears that astrocytes comprising the GL contribute to ADP-induced pial arteriolar relaxation through a P 2 Y 1 receptor-initiated mechanism. Whether that mechanism involves a diffusible or a mechanical factor (or something else) remains to be established.
